CORMORANT ASSET MANAGEMENT, LLC Information

100 HIGH STREET, SUITE 1105, BOSTON, Massachusetts, 02110, (617) 848-3429

Report Date: 12/31/2014

Position Statistics

Total Positions 75
New Positions 11
Increased Positions 27
Decreased Positions 16
Positions with Activity 43
Sold Out Positions 6
Total Mkt Value (in $ millions) 792

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.

Sector Weighting

Basic Materials
Capital Goods
Conglomerates 15.89%
Consumer Cyclical
Consumer/Non-Cyclical
Energy
Financial
Healthcare 57.96%
Services
Technology
Transportation
Utilities

75 Positions as of 12/31/2014

Company Class Value of Shares ($1,000s) ▼ Change in Value ($1,000s) Change (%) Shares Held
NOVAVAX INC COM 12,975 New 1,500,000
KARYOPHARM THERAPEUTICS INC COM 12,559 New 385,000
KERYX BIOPHARMACEUTICALS INC COM 11,730 New 1,000,000
SYNAGEVA BIOPHARMA CORP COM 10,759 New 100,000
AUSPEX PHARMACEUTICALS INC COM 10,089 New 100,000
HERON THERAPEUTICS INC COM 9,968 New 700,000
CHINA BIOLOGIC PRODS INC COM 8,905 -495 (5.26) 90,000
ACCELERON PHARMA INC COM 8,560 -5,136 (37.5) 250,000
BIOCRYST PHARMACEUTICALS COM 8,424 -3,159 (27.27) 800,000
ULTRAGENYX PHARMACEUTICAL INC COM 8,268 New 120,000
SANGAMO BIOSCIENCES INC COM 7,770 New 500,000
RECRO PHARMA INC COM 7,588 New 700,000
ARRAY BIOPHARMA INC COM 7,310 New 1,000,000
APTOSE BIOSCIENCES INC COM NEW 6,912 6,912 New 1,083,333
ALDER BIOPHARMACEUTICALS INC COM 6,338 2,535 66.67 250,000
COHERUS BIOSCIENCES INC COM 5,422 5,422 New 222,200
AGENUS INC COM NEW 5,096 956 23.08 800,000
NEKTAR THERAPEUTICS COM 4,977 New 450,000
DICERNA PHARMACEUTICALS INC COM 4,886 4,886 New 200,000
FORWARD PHARMA A/S SPONSORED ADR 4,814 4,814 New 150,000